View More Recent Stories

Feb 13, 2025 10:19AM Increasing unusual call option volume: EWW CRSR CENX BROS IAU TEM
Feb 12, 2025 09:40AM Tempus AI stock downgraded by William Blair after massive rally
Feb 12, 2025 07:15AM William Blair Downgrades Tempus AI Inc (TEM) to Market Perform
Feb 6, 2025 06:03AM Increasing unusual put option volume: FMC EA HBAN TPX ICE EXE TKO BBAI MTCH TEM
Feb 5, 2025 10:18AM Increasing unusual call option volume: DINO BCRX FMC ACB EA VSH TEM GPRO SAN JCI
Feb 5, 2025 07:00AM TD Cowen Reinstates Tempus AI Inc (TEM) at Buy
Feb 3, 2025 10:23AM Tempus AI (TEM) call put ratio 3.1 calls to 1 put into quarter results
Jan 31, 2025 10:42AM Tempus AI (TEM) call put ratio 5.5 calls to 1 put with a focus on July 70 calls into quarter results
Jan 28, 2025 08:02AM Genialis Advances Biomarker Discovery to Reduce Risk in Cancer Drug Development Targeting DNA Damage Response Pathways (TEM)
Jan 24, 2025 06:15AM Increasing unusual put option volume: EWC EA YOU XLI EDR MLCO BTG HIMX VERU ALK TKO TEM
Jan 21, 2025 11:24AM Tempus AI (TEM) call put ratio 3 calls to 1 put with as share price up 39%
Jan 21, 2025 10:16AM Increasing unusual put option volume: LW FTAI WMB WEN XP FAST CFG RGTI CLMT IYR TEM
Jan 21, 2025 08:33AM Tempus AI (TEM) Announces National Launch of olivia, its AI-enabled Personal Health Concierge App for Patients
Jan 15, 2025 08:32AM Tempus AI (TEM) Announces the National Launch of FDA-Approved xT CDx Test
Jan 14, 2025 07:20AM Tempus AI Inc (TEM) PT Lowered to $52 at Loop Capital
Jan 13, 2025 08:33AM Tempus AI (TEM) Announces xH
Jan 13, 2025 08:02AM Tempus AI (TEM) Announces Preliminary Fourth Quarter and Full Year 2024 Results
Jan 8, 2025 11:59AM Tempus AI (TEM) Announces a Collaboration With Genialis to Develop RNA-Based Biomarker Algorithms
Nov 12, 2024 07:56AM Tempus AI Inc (TEM) PT Raised to $70 at Piper Sandler
Nov 11, 2024 03:23AM Stifel Downgrades Tempus AI Inc (TEM) to Hold
Nov 5, 2024 06:28AM Tempus AI Inc (TEM) PT Raised to $56 at Needham
Nov 4, 2024 04:01PM Tempus AI (TEM) to Acquire Ambry Genetics, Reports Q3
Oct 21, 2024 07:01AM Avacta and Tempus (TEM) Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology
Oct 15, 2024 07:21AM Tempus AI Inc (TEM) PT Raised to $57 at Loop Capital
Sep 4, 2024 08:32AM Tempus AI (TEM) Announces Real World Data Collaboration with BioNTech (BNTX)
Aug 16, 2024 08:31AM Personalis, Inc. (PSNL) and Tempus (TEM) Expand Collaboration
Aug 12, 2024 03:50AM Piper Sandler Starts Tempus AI Inc (TEM) at Neutral
Aug 7, 2024 05:02AM Tempus AI, Inc (TEM) Reports Q2 Loss of $6.86; offers guidance
Jul 9, 2024 09:33AM BofA Securities Starts Tempus AI Inc (TEM) at Buy
Jul 9, 2024 08:55AM Wall Street starts Tempus AI coverage after IPO, shares climb
Jul 9, 2024 07:14AM Loop Capital Starts Tempus AI Inc (TEM) at Buy
Jul 9, 2024 07:09AM William Blair Starts Tempus AI Inc (TEM) at Outperform
Jul 9, 2024 05:54AM Needham Starts Tempus AI Inc (TEM) at Buy
Jul 9, 2024 05:54AM TD Cowen Starts Tempus AI Inc (TEM) at Buy, 'largest oncology Dx co.'
Jul 9, 2024 04:35AM Morgan Stanley Starts Tempus AI Inc (TEM) at Overweight
Jul 9, 2024 03:53AM JPMorgan Starts Tempus AI Inc (TEM) at Overweight
Jul 9, 2024 03:22AM Stifel Starts Tempus AI Inc (TEM) at Buy
Jun 26, 2024 09:30AM Tempus AI (TEM) Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF
Jun 17, 2024 05:42AM Tempus AI (TEM) Prices 11.1M Share IPO at $37/sh
Jun 14, 2024 11:50AM Tempus AI (TEM) IPO Opens Higher by 8%
Jun 14, 2024 10:22AM Tempus AI (TEM) Indicated At $47, IPO Priced At $37
View More Recent Stories